Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 15, 2024
Management
of
low-density
lipoprotein
cholesterol
(LDL-C)
in
stroke
is
a
crucial
component
cardiovascular
disease
care.
Recent
years
have
seen
substantial
progress
understanding
and
managing
LDL-C
the
context
stroke.
This
study
utilized
bibliometric
methods
to
analyze
synthesize
trends
this
area
over
past
decade,
incorporating
2,841
publications
from
Web
Science
database.
The
analyses
included
trend
topic
analysis,
co-authorship
co-citation
analysis.
findings
indicate
that
research
had
predominantly
concentrated
on
epidemiological
studies
related
pharmacological
management
strategies.
Future
expected
continue
exploring
lipid-lowering
therapies,
including
both
established
treatments
like
statins
newer
drugs
such
as
proprotein
convertase
subtilisin-kexin
type
9
inhibitors.
Assessing
residual
employing
Mendelian
randomization
techniques
may
become
potential
hotspots.
Lipids in Health and Disease,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Feb. 17, 2025
This
study
aimed
to
examine
the
relationships
between
remnant
cholesterol
(RC)
and
risk
of
aortic
aneurysm
dissection
(AAD).
prospective
cohort
included
368,139
European
adults
from
UK
Biobank.
Additionally,
causal
relationship
RC
AAD
was
investigated
using
Mendelian
randomization
(MR)
analyses.
During
a
median
follow-up
13.65
years,
1,634
cases
abdominal
(AAA),
698
thoracic
(TAA),
184
(AD)
were
identified.
Elevated
levels
associated
with
an
increased
AAA
compared
reference
group
([highest
vs.
lowest
levels]:
adjusted
hazard
ratio
(HR)
=
1.65,
95%
CI:
1.36–1.99).
However,
no
significant
association
observed
high
either
TAA
or
AD.
Two-sample
MR
analyses
supported
effect
on
(odds
(OR)
2.08,
1.70–2.56).
The
persisted
after
adjusting
for
effects
RC-associated
genetic
variants
low-density
lipoprotein
(LDL-C).
In
contrast,
did
not
indicate
any
associations
linked
greater
developing
AAA,
confirming
relationship.
These
findings
suggest
that
may
function
as
new
biomarker
could
be
integral
strategies
at
preventing
AAA.
Current Opinion in Clinical Nutrition & Metabolic Care,
Journal Year:
2023,
Volume and Issue:
27(2), P. 125 - 135
Published: Nov. 21, 2023
Purpose
of
review
Atherosclerotic
cardiovascular
disease
(ASCVD)
is
the
leading
cause
death
despite
development
effective
treatments.
Recently,
elevated
remnant
cholesterol
and
low-grade
inflammation
have
emerged
as
factors
explaining
part
residual
ASCVD
risk.
Interestingly,
coexistence
both
high
can
further
increase
risk
ASCVD.
The
aim
this
to
describe
role
inflammation,
separately
combined,
in
Recent
findings
Results
from
recently
published
studies,
including
observational
genetic
Mendelian
randomization
support
a
causal
relationship
between
on
primary
secondary
prevention
settings.
In
addition,
current
evidence
studies
suggests
that
increases
Summary
suggest
combined
with
may
confer
particular
for
Attention
dual
threat
necessary,
research
field
warranted.
effect
cholesterol-lowering
drugs
anti-inflammatory
alone
remains
be
elucidated.
Video
abstract
http://links.lww.com/COCN/A20
Journal of the American Heart Association,
Journal Year:
2023,
Volume and Issue:
12(14)
Published: July 14, 2023
Background
We
aimed
to
examine
separate
and
joint
associations
of
remnant
cholesterol
(RC)
accumulation
variability
with
the
risk
carotid
atherosclerosis
(CAS)
in
general
population.
Methods
Results
A
total
6213
participants
who
underwent
3
sequential
health
examinations
during
2010
2015
were
enrolled
followed
up
until
December
31,
2021.
Cumulative
RC
(cumRC)
among
visits
exposure
interest
our
study.
Adjusted
Cox
models
performed
calculate
hazard
ratio
(HR)
95%
CI.
C‐statistics,
integrated
discrimination
improvement,
net
reclassification
index
used
estimate
incremental
predictive
ability.
During
a
median
follow‐up
4.00
years,
2613
developed
CAS.
Higher
cumRC
(HR,
1.33
[95%
CI,
1.17–1.52])
greater
1.22
1.08–1.39])
significantly
associated
elevated
CAS,
independent
traditional
cardiovascular
factors
low‐density
lipoprotein
cholesterol.
Participants
divided
into
4
groups
according
assess
their
associations.
Compared
“low
low
variability,”
“high
high
variability”
had
highest
by
variability.”
Finally,
assessment
effect
on
value
CAS
versus
single‐time‐point
measures
RC.
Conclusions
Excessive
levels
each
independently
higher
incidence
coexistence
could
further
yield
risks.
Journal of the American Heart Association,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Background
Although
the
association
between
remnant
cholesterol
(RC)
and
cognitive
impairment
has
been
reported,
of
RC
with
decline
remains
scarce.
Also,
role
lipid‐lowering
therapy
in
is
unclear.
The
study
aimed
to
examine
longitudinal
associations
by
drug
use
during
follow‐up.
Methods
Results
used
data
from
Wave
2
(2004–2005)
8
(2016–2017)
ELSA
(English
Longitudinal
Study
Ageing).
Global
functions
at
baseline
(Wave
2)
follow‐up
(Waves
3–8)
were
assessed
integrating
3
domains:
memory
capacity,
semantic
fluency,
orientation.
Multivariate‐adjusted
linear
mixed
models
employed
associations,
results
presented
as
β
(95%
CI)
SD/year.
Of
5053
participants
ultimately
included,
55.4%
female
mean
age
(SD)
was
65.7
(9.3)
years.
Per
1
mmol/L
increment
significantly
associated
a
faster
rate
(
=−0.010
SD/year
[95%
CI
−0.019
−0.001]).
Furthermore,
we
observed
that
pattern
only
non‐lipid‐lowering
group
=−0.019
CI,
−0.031
−0.007])
but
not
=0.007
−0.006
0.020]),
significant
interaction
P
=0.015).
Similar
findings
for
domains.
Conclusions
Higher
levels
steeper
decline.
drugs
might
mitigate
this
These
underscore
importance
early
monitoring
proactive
management
clinical
practice.
Frontiers in Aging Neuroscience,
Journal Year:
2024,
Volume and Issue:
16
Published: Feb. 12, 2024
Background
and
aims
Amnestic
mild
cognitive
impairment
(aMCI)
is
the
most
common
subtype
of
MCI,
which
carries
a
significantly
high
risk
transitioning
to
Alzheimer’s
disease.
Recently,
increasing
attention
has
been
given
remnant
cholesterol
(RC),
non-traditional
previously
overlooked
factor.
The
aim
this
study
was
explore
association
between
plasma
RC
levels
aMCI.
Methods
Data
were
obtained
from
Brain
Health
Cognitive
Management
Team
in
Wuhan
(
https://hbtcm.66nao.com/admin/
).
A
total
1,007
community-dwelling
elders
recruited
for
project.
Based
on
ten
tools
including
general
demographic
data,
screening
some
exclusion
scales,
these
participants
divided
into
aMCI
n
=
401)
normal
groups
606).
Physical
examinations
conducted
all
participants,
with
clinical
indicators
such
as
blood
pressure,
sugar,
lipids
collected.
Results
group
had
higher
compared
(0.64
±
0.431
vs.
0.52
0.447
mmol/L,
p
<
0.05).
Binary
logistics
regression
revealed
that
occupation
P
<0.001,
OR
0.533,
95%CI:
0.423–0.673)
0.014,
1.477,
95%
CI:1.081–2.018)
associated
factors
Partial
correlation
analysis,
after
controlling
occupation,
showed
significant
negative
MoCA
scores
r
0.059,
0.046),
well
Naming
0.070,
0.026).
ROC
curve
analysis
demonstrated
an
independent
predictive
efficacy
predicting
(AUC
0.580,
0.544
~
0.615,
0.001).
Conclusion
Higher
identified
indicator
aMCI,
particularly
naming
domain
among
older
individuals.
Further
longitudinal
studies
are
necessary
validate
RC.
Frontiers in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Feb. 7, 2024
Introduction
Triglyceride-rich
remnant
lipoproteins
(TRLs)
are
considered
atherogenic
due
to
the
presence
of
cholesterol,
which
is
transported
by
apolipoprotein
B.
In
clinical
practice,
concentration
TRLs
can
be
estimated
calculating
cholesterol
or
non-HDL
levels.
Aim
This
study
aims
investigate
proportion
patients
who
have
low
LDL
(LDL-C)
but
elevated
concentration,
stratified
hypertriglyceridaemia
and
ethnicity,
using
real-world
hospital
data.
Our
secondary
aim
with
levels
guideline-recommended
goals.
Methods
A
2-year
retrospective
was
conducted
at
a
single
centre,
analyzing
lipid
blood
tests
all
patients,
including
directly
measured
LDL-C.
Fasting
for
not
mandatory.
Results
The
included
total
21,605
consecutive
plasma
profiles
analyzed
in
our
laboratory.
median
age
61
years.
ASCVD
(
n
=
14,704),
23.7%
had
an
LDL-C
level
<1.8
mmol/L,
11.3%
concentrations
≥0.65
48.8%
were
non-high-density
lipoprotein
(non-HDL-C)
goal
(<2.6
mmol/L).
Among
diagnosed
atherosclerotic
cardiovascular
disease
(ASCVD)
mmol/L
3,484),
only
11.9%
high
96%
also
achieved
recommended
non-HDL-C
target
<2.6
mmol/L.
When
mean
0.214
when
triglyceride
<1.7
3,380),
vs.
0.70
724),
p
<
0.001.
≥1.7
<.8
there
254
71
suboptimal
Malays
higher
compared
both
Chinese
Indians
across
levels,
particularly
hypertriglyceridaemia.
Conclusions
An
>0.65
present
11%
patients.
current
goal,
uses
0.8
estimate
>92%
suggesting
that
it
unlikely
clinically
useful
majority
patient
population
except
where
concomitant
Further
studies
needed
establish
appropriate
calculated
paired
otherwise,
Southeast
Asian
population.